Vascular Clinical Trials
CLI & AMI

Blood and Bone Marrow
Bioprocessing

Bone Marrow Transplant
Innovation

News Updates

CESCA THERAPEUTICS RECEIVES NOTICE OF NON-COMPLIANCE WITH NASDAQ LISTI...

February 27, 2015

Rancho Cordova, CA, February 27, 2015 -- Cesca Therapeutics Inc. (Nasdaq: KOOL), an autologous cell-...

Read More >>

CESCA THERAPEUTICS REPORTS SECOND QUARTER FISCAL 2015 RESULTS

February 12, 2015

Company to Provide an Update on the Status of its IDE Submission to the FDA for a Phase III Pivotal...

Read More >>

Video Library